Toward interchangeable biologics

Clin Pharmacol Ther. 2015 Mar;97(3):215-7. doi: 10.1002/cpt.39. Epub 2015 Jan 21.

Abstract

A biosimilar is designed to match the reference product--to be as close to the reference as the reference is to itself considering batch-to-batch variability and manufacturing changes over its lifetime. Interchangeability will require additional data, however, the interchangeable biologic itself will be the same as that approved for biosimilarity.

MeSH terms

  • Biosimilar Pharmaceuticals / standards*
  • Drug Approval*
  • Drug Discovery / standards*
  • Humans

Substances

  • Biosimilar Pharmaceuticals